MEDITE Cancer Diagnostics

MEDITE® Group is a medical technology company specializing in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases.

Executive Summary

MEDITE is poised to become a disruptive force from rapid revenue and market share growth resulting from the introduction of major innovative products in the multibillion dollar global histology and cytology cancer detection marketplace.

Read the Full Summary

Investor Contact

Investor relations provided by KCSA Strategic Communications.

Email KCSA to find out more information on investment opportunities with MEDITE Cancer Diagnostics.
medite@kcsa.com